Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
about
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infectionsKetolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.In vivo efficacy of the ketolide ABT-773 (cethromycin) against enterococci in a mouse peritonitis modelCethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacinInvestigational new drugs for the treatment of resistant pneumococcal infections.Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.Advances in MRSA drug discovery: where are we and where do we need to be?Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitroSteady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.Cethromycin: a promising new ketolide antibiotic for respiratory infections.Antibiotics in development targeting protein synthesis.Cethromycin: a new ketolide antibiotic.Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs varyEfficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.
P2860
Q33767602-FF7AB148-DBF0-4AB0-9A75-52D946D7CEA5Q34281970-DC61736A-D021-4A99-B601-0EA6601A5597Q34335695-52B69D82-F04B-4D2A-97EE-8AFBD92B69AAQ35166042-73AEFE85-CF21-475E-9B51-E5EE7F6B0EA0Q35363899-3FD7ED9D-B940-4E43-BAEA-81B30A1EFA97Q36210902-22178DCC-2CA0-437C-9128-BB96540F1988Q36936597-B33C3F03-36EA-475E-BE07-620C4BF733C7Q37112508-3E8E242C-0B3D-4A58-9D7B-ACD1A73285E1Q37119314-89682808-FA1F-486B-A226-BF30258B8307Q37489476-59286A67-F024-4161-AAEB-E7E221F62919Q37568933-8152FD8F-0E7A-4139-9AFE-E273B0F06357Q37697782-8F676705-00EF-468D-8FAD-D3EE47D64352Q37970724-477C2C5B-F508-449E-BD32-2B6A7EE5E1C9Q38086821-5EC54E81-8DC7-4E57-ADC8-887AD690480BQ42252396-F622A084-F02D-4497-9CCD-54546DE83D85Q43151670-F2F69C26-6646-43BC-ABD1-0A3EBDA78580
P2860
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Bactericidal effect and pharma ...... pneumococcal pneumonia model.
@ast
Bactericidal effect and pharma ...... pneumococcal pneumonia model.
@en
Bactericidal effect and pharmacodynamics of cethromycin
@nl
type
label
Bactericidal effect and pharma ...... pneumococcal pneumonia model.
@ast
Bactericidal effect and pharma ...... pneumococcal pneumonia model.
@en
Bactericidal effect and pharmacodynamics of cethromycin
@nl
prefLabel
Bactericidal effect and pharma ...... pneumococcal pneumonia model.
@ast
Bactericidal effect and pharma ...... pneumococcal pneumonia model.
@en
Bactericidal effect and pharmacodynamics of cethromycin
@nl
P2093
P2860
P1476
Bactericidal effect and pharma ...... pneumococcal pneumonia model.
@en
P2093
Charles H Nightingale
David P Nicolau
Dawei Xuan
Myo-Kyoung Kim
Pamela R Tessier
P2860
P304
P356
10.1128/AAC.46.10.3185-3192.2002
P407
P577
2002-10-01T00:00:00Z